Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2019-12-26FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)
FDA approved a supplemental application for OTREXUP (methotrexate) from Antares Pharma, Inc., leading to changes in the labeling for this su…
-
FDA approval · 2019-12-18FDA Approved: ARAZLO — Original Application (Bausch Health US, LLC)
The FDA approved ARAZLO, a tazarotene topical lotion, under an original application by Bausch Health US, LLC for the treatment of plaque pso…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis [Phase 2]
Phase 2 trial of calcitriol BID topical treatment in adolescents with chronic plaque psoriasis has completed; results posted.
-
FDA approval · 2019-12-06FDA Approved: AVSOLA — Original Application (Amgen, Inc)
FDA approved AVSOLA (infliximab-axxq) from Amgen as a biosimilar to infliximab, for the same indications as the reference product.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
Phase 2 extension trial assessing safety and efficacy of risankizumab (BI 655066/ABBV-066) in moderate to severe chronic plaque psoriasis ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-21FDA Approved: CLOBETASOL PROPIONATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' original ANDA for clobetasol propionate topical.
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial comparing CHS-1420 to Humira in chronic plaque psoriasis has completed with results posted.
-
FDA approval · 2019-10-02FDA Approved: CLOBETASOL PROPIONATE — Original Application (Micro Labs Limited)
The FDA approved Micro Labs Limited's original application for clobetasol propionate topical, a potent corticosteroid, for inflammatory and …
-
FDA approval · 2019-10-02FDA Approved: CLOBETASOL PROPIONATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for clobetasol propionate topical, a high-potency corticosteroid, enabli…
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis. [Phase 4]
Phase 4 trial investigating the impact of a treatment on quality of life in patients with plaque psoriasis; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy [Phase 3]
A Phase 3 trial comparing risankizumab to FUMADERM in adults with moderate to severe plaque psoriasis has completed and posted results.
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for clobetasol propionate from Sun Pharmaceutical Industries under an ANDA.
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE EMOLLIENT FORMULATION — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for a clobetasol propionate emollient formulation from Padagis Israel Pharmaceuticals Ltd, granting …
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for clobetasol propionate from Sun Pharmaceutical Industries, enhancing its approval under the gener…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp [Phase 3]
Phase 3 trial assessing efficacy and safety of Apremilast (CC-10004) for moderate to severe plaque psoriasis of the scalp; study completed w…
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 dose-ranging trial in moderate to severe plaque psoriasis completed; results posted.
-
FDA approval · 2019-07-30FDA Approved: ENSTILAR — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application for ENSTILAR (calcipotriene and betamethasone dipropionate) from LEO Pharma Inc.
-
FDA label_change · 2019-07-25FDA Approved: TACLONEX — Supplemental Application (LEO Pharma Inc.)
The FDA approved a supplemental application for TACLONEX (calcipotriol and betamethone dipropionate) from LEO Pharma Inc., resulting in chan…
-
FDA approval · 2019-07-23FDA Approved: HADLIMA — Original Application (Organon LLC)
FDA approves Hadlima (adalimumab-bwwd) from Organon as a biosimilar to Humira under the original application BLA761059. It is indicated for …
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial comparing secukinumab to ustekinumab in subjects with plaque psoriasis has completed and posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis [Phase 4]
Phase 4 trial evaluating secukinumab versus placebo on aortic vascular inflammation in moderate to severe plaque psoriasis completed with re…
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
Clinical trial update assessing the efficacy of etanercept over 12 months in routine treatment of rheumatoid arthritis and related inflammat…
-
FDA approval · 2019-06-13FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
The FDA approved a supplemental application for AMJEVITA (adalimumab-atto) submitted by Nuvaila Limited.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis [Phase 2]
Phase 2 trial of a botanical drug (EISO) for mild-to-moderate plaque psoriasis has completed with results posted.
-
FDA approval · 2019-05-24FDA Approved: CALCIPOTRIENE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Calcipotriene by Glenmark Pharmaceuticals Inc., USA.